Spinal Cord Injury Market to Observe Impressive Growth by 2032, Evaluates DelveInsight | Key Companies – ReNetX Bio, AbbVie, StemCyte, Nipro Corp., Kringle Pharma, Lineage Cell Therapeutics

Delveinsight Business Research LLP
As per DelveInsight, the Spinal Cord Injury (SCI) Market size shall grow during the forecast period, owing to the launch of upcoming therapies. Extensive research and development activities of pharmaceutical companies for developing therapies for SCI will also significantly impact the market growth.

DelveInsight’s “Spinal Cord Injury Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Spinal Cord Injury Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Spinal Cord Injury market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of opportunities and assess the underlying potential of the market. 

Spinal Cord Injury: An Overview

Spinal Cord Injury (SCI) is a devastating event with sudden onset of motor and sensory dysfunction. Damage to autonomic neurons at and below the level of injury leads to bowel, bladder, and sexual functional loss. Prevalence of this trauma was formerly found primarily in young patients due to high-energy accidents and contact sports. However, cervical canal stenosis is increasingly found in elderly patients with the progress of our aging society and the susceptibility of elderly patients to easily injure their spinal cord from a fall.

There is no specific treatment for SCI patients, and currently, surgical intervention and subsequent rehabilitation are the only options for SCI treatment. Although methylprednisolone is administered at the acute stage of injury, a consensus of its use has not yet been reached from the aspects of both safety and effectiveness.

Recent developments in stem cell research and numerous preclinical studies have demonstrated the effectiveness of neural precursor cell (NPC) transplantation in animal models of SCI.

Spinal Cord Injury Market Key Facts

The total prevalent population of Spinal cord injury (SCI) in the 7MM was 652,500+ in 2017.

According to the analysts at Delveinsight, the highest prevalent cases of this disease were observed in the United States, which accounted for 294,000+ cases in 2017.

The total prevalent cases of Spinal Cord Injury (SCI) were highest in the United States, followed by Germany and France. Spain accounted for the least number of prevalent cases among the 7MM.

In 2017, the incident population of Spinal Cord Injury in Japan was found to be 5,000+ cases, and the prevalence was estimated to be 100,000 cases.

According to the available literature, Vehicle crashes are the most recent leading cause of injury, closely followed by falls. Sports and work-related accidents are the other major causes of injury. 

Spinal Cord Injury Market

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Spinal Cord Injury market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report details the Spinal Cord Injury market trend for each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Spinal Cord Injury (SCI) Market Dynamics:

Absence of therapies in the market

Increase in the affected population

Poor efficacy and side effects associated with current therapies

Spinal Cord Injury Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Spinal Cord Injury (SCI) Epidemiology Segmentation

Prevalent cases of Spinal Cord Injury

Incident cases of Spinal Cord Injury

Prevalence of Spinal Cord Injury by Causes

Gender-wise Prevalence of Spinal Cord Injury

Prevalence of Spinal Cord Injury at Neurological Level

Spinal Cord Injury Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Spinal Cord Injury market or expected to get launched during the study period. The analysis covers Spinal Cord Injury market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Spinal Cord Injury Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report – https://www.delveinsight.com/sample-request/spinal-cord-injury-market

Spinal Cord Injury Therapeutics Analysis

The dynamics of the Spinal Cord Injury market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, raising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies during the forecast period.

Companies across the globe are working toward developing new treatment therapies for Spinal Cord Injury, but few companies have made it to the clinical stage of development.

Some of the key Companies in the Spinal Cord Injury (SCI) Market include:

AbbVie

StemCyte

Kringle Pharma

Lineage Cell Therapeutics

Nipro Corporation

ReNetX Bio, Inc.

And many others. 

Spinal Cord Injury (SCI) Therapies covered in the report include:

MC001

AST-OPC1

KP-100IT

Elezanumab

Stemirac

AXER-204

And many more.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –  https://www.delveinsight.com/sample-request/spinal-cord-injury-market

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Spinal Cord Injury Competitive Intelligence Analysis

4. Spinal Cord Injury Market Overview at a Glance

5. Spinal Cord Injury Disease Background and Overview

6. Spinal Cord Injury Patient Journey

7. Spinal Cord Injury Epidemiology and Patient Population

8. Spinal Cord Injury Treatment Algorithm, Current Treatment, and Medical Practices

9. Spinal Cord Injury Unmet Needs

10. Key Endpoints of Spinal Cord Injury Treatment

11. Spinal Cord Injury Marketed Products

12. Spinal Cord Injury Emerging Therapies

13. Spinal Cord Injury Seven Major Market Analysis

14. Attribute Analysis

15. Spinal Cord Injury Market Outlook (7 major markets)

16. Spinal Cord Injury Access and Reimbursement Overview

17. KOL Views on the Spinal Cord Injury Market.

18. Spinal Cord Injury Market Drivers

19. Spinal Cord Injury Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report – https://www.delveinsight.com/sample-request/spinal-cord-injury-market

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.

 

Other Latest Healthcare Reports by DelveInsight

Mucopolysaccharidosis I Market
“Mucopolysaccharidosis I Market” research report provides a detailed overview of the disease, an in-depth understanding of the historical and forecasted epidemiology, market size, share, trends, ongoing developments, as well as the key companies and the emerging therapies in the Mucopolysaccharidosis I Therapeutics Market.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Are you a market researcher?

Explore our research partnership options.

Partnerships

Find out what people like and dislike about your competitors, and compare it with your brand performance.

Competitor Analyzer

Generated by Feedzy
%d bloggers like this: